Retinopatia Diabética: Prevenção e Tratamento: Um exame das medidas de prevenção, monitoramento e opções terapêuticas para pacientes com retinopatia diabética.

• Autor(a) principal: Tanuri, Filipe Duarte
• Data de Publicação: 2023
• Outros Autores: Vasconcelos , Pedro Alves Queiroz, Gonzalez, Pablo Sebastian Guadalupe, Santos , Gustavo Dias Marques dos, Martins , Felipe Miranda dos Santos, Santos , Giovanna Leal Cruz, Canali , Bruna Vergani, Dias , Marcus Vinícius Pinto do Amaral, Santos , Letícia Layra Simon dos, Braia, Ana Vitória Gabriel, Bezerra, Christine Estenya Campos, Rego, Myrella Zágna Leite do
• Tipo de documento: Artigo
• Idioma: por
• Título da fonte: Brazilian Journal of Implantology and Health Sciences
• Texto Completo: https://bjihs.emnuvens.com.br/bjihs/article/view/707
• topic: Retinopatia Diabética; Prevenção; Monitoramento; Opções Terapêuticas; Controle Glicêmico

Diabetic retinopathy is a prevalent and debilitating eye complication associated with diabetes mellitus. This review article addresses prevention measures, monitoring, and therapeutic options for patients with diabetic retinopathy, emphasizing its clinical importance and impact on patients' quality of life. In prevention, strict glycemic control and blood pressure management play central roles in reducing the risk and progression of diabetic retinopathy. Patient education is also crucial in promoting healthy habits. Regular retinal monitoring through fundus photography, optical coherence tomography (OCT), and OCTA angiography enables early detection of retinal changes, allowing for timely interventions. In the field of therapeutic options, intravitreal injections of anti-angiogenics, such as ranibizumab and bevacizumab, have revolutionized the treatment of diabetic macular edema (DME) and improved patients' vision. Therapies based on vascular growth factors, such as aflibercept, offer promising therapeutic alternatives. Managing diabetic retinopathy requires multidisciplinary approaches involving ophthalmologists, endocrinologists, and health educators. Personalizing treatment based on the disease stage and the individual patient's response is essential. Ongoing advances in clinical and technological research offer hope for better control and treatment of diabetic retinopathy, with the goal of preserving vision and enhancing patients' quality of life.